NCT06999759

Brief Summary

The aim of this study was to present the results of the effect of concealing chemotherapy drug serum with a picture box on children's anxiety, nausea and vomiting. The study was planned with children aged 5-10 years who met the inclusion criteria. In this randomised controlled study, 70 children with cancer who are hospitalised in Marmara University Hospital and meet the inclusion criteria will be divided into two equal groups. The first group (intervention group) receives chemotherapy in chemotherapy boxes in which pictures made by the children are pasted before starting chemotherapy. In the second group (control group), children do not draw and chemotherapy boxes are not used. In both groups, the'' Child Anxiety Scale - State Anxiety Scale'' and the' Nausea - Vomiting Thermometer Scale in Children with Cancer'' will be used to assess children's state anxiety and nausea and vomiting. The scores given by the children will be noted by the researcher and the observer 5 minutes before the treatment and immediately after the end of the treatment in the scale scores section of the 'Child monitoring and evaluation form during chemotherapy'.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

May 7, 2025

Last Update Submit

May 23, 2025

Conditions

Keywords

ChemotherapyChemotherapy drug serumChildAnxietyNausea and Vomiting

Outcome Measures

Primary Outcomes (1)

  • . The change in child anxiety scale state scale (CAS-D) scores of the group receiving chemotherapy drug serum with picture box

    It was determined 5 minutes before the planned therapeutic process and immediately after the end of the treatment with the ''Child Anxiety Scale-Situation Scale''.An increase in the scale score indicates an increase in the child's anxiety. The total score varies between 0-10 points.The lowest score that can be selected from the scale is ''0'' and the highest score is ''10''.

    5 minutes before the start of chemotherapy medication and immediately after the end of treatment.]

Secondary Outcomes (1)

  • Change in nausea-vomiting thermometer scale (NVT) scores of the group receiving chemotherapy drug serum with picture box.

    5 minutes before the start of chemotherapy medication and immediately after the end of treatment.

Study Arms (2)

group of cute serum boxes

EXPERIMENTAL

Children in the study group were provided with cute picture boxes with their own pictures hanging on them to receive chemotherapy.

Device: cute serum boxOther: coloring book and coloring pencils

Control Group

NO INTERVENTION

The chemotherapy drug serum of the children in the control group was not concealed by the designed picture box, and they continued their treatment routinely.

Interventions

After the children in the intervention group were made to draw pictures, they were glued to the designed cute serum box and chemotherapy drug serum was hidden and they were provided to receive their treatment.

group of cute serum boxes

Children in the intervention group were provided with a coloring book and coloring pencils to make a picture to hang on the picture box.

group of cute serum boxes

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • years old (The scale used is between this age group, these children should be willing to draw and should be suitable for their developmental periods)
  • Inpatients with cancer,
  • Those receiving the second and subsequent courses of chemotherapy,
  • Previous chemotherapy experience,
  • Those receiving chemotherapy drugs, the duration of chemotherapy lasting an average of 1 to 6 hours
  • Those taking chemotherapy drugs with minimal, low and moderate severity of nausea and vomiting,
  • Children whose parents agreed to participate in the study were included in the study.

You may not qualify if:

  • Those in the last stage of cancer (experiencing the side effects of treatment intensively during hospitalisation due to the disease and symptoms causing complications)
  • Those receiving oral chemotherapy,
  • Those who experience intense side effects of chemotherapy (febrile neutropenia, bleeding, allergic reactions),
  • People with mental problems (depression, anxiety disorders, disruptive behaviour disorders, neurodevelopmental disorders),
  • People on antidepressant medication,
  • Those who have a physical disability (e.g. amputation, lack/inability to use arms, hands and fingers, visual or hearing impairment, etc.) to paint during chemotherapy, and
  • Children taking medicines with high severity of nausea and vomiting were not included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara Unıvesıty Educatıon And Research Hospıtal Istanbul, Pendik, Turkey, 34000 .

Istanbul, 34000, Turkey (Türkiye)

Location

Related Publications (13)

  • Saeidzadeh S, Kamalumpundi V, Chi NC, Nair R, Gilbertson-White S. Web and mobile-based symptom management interventions for physical symptoms of people with advanced cancer: A systematic review and meta-analysis. Palliat Med. 2021 Jun;35(6):1020-1038. doi: 10.1177/02692163211006317. Epub 2021 Apr 12.

    PMID: 33840271BACKGROUND
  • Çavuşoğlu, H. (2019). Çocuk Sağlığı Hemşireliği. Cilt 2, Ankara: Sistem Ofset Matbaacılık.

    BACKGROUND
  • Withycombe JS, Haugen M, Zupanec S, Macpherson CF, Landier W. Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment. J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):294-299. doi: 10.1177/1043454219854983.

    PMID: 31307318BACKGROUND
  • Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019 Apr;20(4):483-493. doi: 10.1016/S1470-2045(18)30909-4. Epub 2019 Feb 26.

    PMID: 30824204BACKGROUND
  • Tripathi, A. K., David, A., Govil, T., Rauniyar, S., Rathinam, N. Κ., Goh, K. M., Sani, R. K. (2020). Environmental Remediation of Antineoplastic Drugs: Present Status, Challenges, and Future Directions. Processes, 8(7), 747. doi:10.3390/pr8070747.

    BACKGROUND
  • Nie Y, Tian Y, Han X. Music Nursing as Complementary Therapy Improves Anxiety, Fatigue, and Quality of Life in Children with Acute Leukaemia: A Retrospective Study. Noise Health. 2024 Jan-Mar 01;26(120):25-29. doi: 10.4103/nah.nah_33_24. Epub 2024 Mar 23.

    PMID: 38570307BACKGROUND
  • Myers RM, Balsamo L, Lu X, Devidas M, Hunger SP, Carroll WL, Winick NJ, Maloney KW, Kadan-Lottick NS. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer. 2014 May 1;120(9):1417-25. doi: 10.1002/cncr.28578. Epub 2014 Jan 28.

    PMID: 24473774BACKGROUND
  • Hu H, Shear D, Thakkar R, Thompson-Lastad A, Pinderhughes H, Hecht FM, Lown EA. Acupressure and Therapeutic Touch in Childhood Cancer to Promote Subjective and Intersubjective Experiences of Well-being During Curative Treatment. Glob Adv Health Med. 2019 Sep 30;8:2164956119880143. doi: 10.1177/2164956119880143. eCollection 2019.

    PMID: 31632842BACKGROUND
  • Braam KI, van Dijk-Lokkart EM, Kaspers GJL, Takken T, Huisman J, Buffart LM, Bierings MB, Merks JHM, van den Heuvel-Eibrink MM, Veening MA, van Dulmen-den Broeder E. Effects of a combined physical and psychosocial training for children with cancer: a randomized controlled trial. BMC Cancer. 2018 Dec 27;18(1):1289. doi: 10.1186/s12885-018-5181-0.

    PMID: 30587148BACKGROUND
  • Gerçeker, G. Ö., Ayar, D., Özdemir, Z., ve Bektaş, M. (2018). Çocuk Anksiyete Skalası-Durumluluk ve Çocuk Korku Ölçeğinin Türk Diline Kazandırılması. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi, 11(1), 9-13.

    BACKGROUND
  • Akdeniz Kudubes A, Bektas M. Developing the Nausea and Vomiting Thermometer Scale in children with cancer. Turk J Med Sci. 2022 Feb;52(1):166-174. doi: 10.3906/sag-2005-88. Epub 2022 Feb 22.

    PMID: 34544217BACKGROUND
  • Altay N, Kilicarslan-Toruner E, Sari C. The effect of drawing and writing technique on the anxiety level of children undergoing cancer treatment. Eur J Oncol Nurs. 2017 Jun;28:1-6. doi: 10.1016/j.ejon.2017.02.007. Epub 2017 Mar 2.

    PMID: 28478846BACKGROUND
  • Aguilar BA. The Efficacy of Art Therapy in Pediatric Oncology Patients: An Integrative Literature Review. J Pediatr Nurs. 2017 Sep-Oct;36:173-178. doi: 10.1016/j.pedn.2017.06.015. Epub 2017 Jun 30.

    PMID: 28888499BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersNauseaVomiting

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gizem ERGÜN

    Maltepe University School of Nursing İstanbul,Turkey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, PhD

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 31, 2025

Study Start

October 3, 2024

Primary Completion

November 10, 2024

Study Completion

May 5, 2025

Last Updated

May 31, 2025

Record last verified: 2025-05

Locations